EUTOS score predicts early optimal response to imatinib according to the revised 2013 ELN recommendations

被引:8
作者
Bonifacio, Massimiliano [1 ]
Binotto, Gianni [2 ]
Calistri, Elisabetta [3 ]
Maino, Elena [4 ]
Tiribelli, Mario [5 ,6 ]
机构
[1] Univ Verona, Dept Med, Sect Hematol, I-37100 Verona, Italy
[2] Padua Sch Med, Dept Med Hematol & Clin Immunol, Padua, Italy
[3] Ca Foncello Hosp, Hematol Unit, Treviso, Italy
[4] DellAngelo Hosp, Hematol Unit, Venice, Italy
[5] Univ Udine, Azienda Osped, Div Hematol, I-33100 Udine, Italy
[6] Univ Udine, Azienda Osped, Dept Expt & Clin Med Sci, BMT, I-33100 Udine, Italy
关键词
CHRONIC MYELOID-LEUKEMIA;
D O I
10.1007/s00277-013-1974-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:163 / 164
页数:2
相关论文
共 6 条
[1]   European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013 [J].
Baccarani, Michele ;
Deininger, Michael W. ;
Rosti, Gianantonio ;
Hochhaus, Andreas ;
Soverini, Simona ;
Apperley, Jane F. ;
Cervantes, Francisco ;
Clark, Richard E. ;
Cortes, Jorge E. ;
Guilhot, Francois ;
Hjorth-Hansen, Henrik ;
Hughes, Timothy P. ;
Kantarjian, Hagop M. ;
Kim, Dong-Wook ;
Larson, Richard A. ;
Lipton, Jeffrey H. ;
Mahon, Francois-Xavier ;
Martinelli, Giovanni ;
Mayer, Jiri ;
Mueller, Martin C. ;
Niederwieser, Dietger ;
Pane, Fabrizio ;
Radich, Jerald P. ;
Rousselot, Philippe ;
Saglio, Giuseppe ;
Saussele, Susanne ;
Schiffer, Charles ;
Silver, Richard ;
Simonsson, Bengt ;
Steegmann, Juan-Luis ;
Goldman, John M. ;
Hehlmann, Ruediger .
BLOOD, 2013, 122 (06) :872-884
[2]   Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML) [J].
Hanfstein, B. ;
Mueller, M. C. ;
Hehlmann, R. ;
Erben, P. ;
Lauseker, M. ;
Fabarius, A. ;
Schnittger, S. ;
Haferlach, C. ;
Goehring, G. ;
Proetel, U. ;
Kolb, H-J ;
Krause, S. W. ;
Hofmann, W-K ;
Schubert, J. ;
Einsele, H. ;
Dengler, J. ;
Haenel, M. ;
Falge, C. ;
Kanz, L. ;
Neubauer, A. ;
Kneba, M. ;
Stegelmann, F. ;
Pfreundschuh, M. ;
Waller, C. F. ;
Branford, S. ;
Hughes, T. P. ;
Spiekermann, K. ;
Baerlocher, G. M. ;
Pfirrmann, M. ;
Hasford, J. ;
Saussele, S. ;
Hochhaus, A. .
LEUKEMIA, 2012, 26 (09) :2096-2102
[3]   Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score [J].
Hasford, Joerg ;
Baccarani, Michele ;
Hoffmann, Verena ;
Guilhot, Joelle ;
Saussele, Susanne ;
Rosti, Gianantonio ;
Guilhot, Francois ;
Porkka, Kimmo ;
Ossenkoppele, Gert ;
Lindoerfer, Doris ;
Simonsson, Bengt ;
Pfirrmann, Markus ;
Hehlmann, Rudiger .
BLOOD, 2011, 118 (03) :686-692
[4]   Assessment of BCR-ABL1 Transcript Levels at 3 Months Is the Only Requirement for Predicting Outcome for Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors [J].
Marin, David ;
Ibrahim, Amr R. ;
Lucas, Claire ;
Gerrard, Gareth ;
Wang, Lihui ;
Szydlo, Richard M. ;
Clark, Richard E. ;
Apperley, Jane F. ;
Milojkovic, Dragana ;
Bua, Marco ;
Pavlu, Jiri ;
Paliompeis, Christos ;
Reid, Alistair ;
Rezvani, Katayoun ;
Goldman, John M. ;
Foroni, Letizia .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (03) :232-238
[5]   PROGNOSTIC DISCRIMINATION IN GOOD-RISK CHRONIC GRANULOCYTIC-LEUKEMIA [J].
SOKAL, JE ;
COX, EB ;
BACCARANI, M ;
TURA, S ;
GOMEZ, GA ;
ROBERTSON, JE ;
TSO, CY ;
BRAUN, TJ ;
CLARKSON, BD ;
CERVANTES, F ;
ROZMAN, C .
BLOOD, 1984, 63 (04) :789-799
[6]   EUTOS score predicts long-term outcome but not optimal response to imatinib in patients with chronic myeloid leukaemia [J].
Tiribelli, Mario ;
Bonifacio, Massimiliano ;
Calistri, Elisabetta ;
Binotto, Gianni ;
Maino, Elena ;
Marin, Luciana ;
Guardalben, Emanuele ;
Branca, Antonio ;
Gherlinzoni, Filippo ;
Semenzato, Gianpietro ;
Sancetta, Rosaria ;
Pizzolo, Giovanni ;
Fanin, Renato .
LEUKEMIA RESEARCH, 2013, 37 (11) :1457-1460